Our InnovationsOur Innovations

Innovations - TopBoards

Lawrence P. English

Lawrence P. English

www.lpenglish.com
Chairman
Lawrence P. English & Associates
Longboat Key, Florida

Present Boards:
QuadraMed Corporation - Strategic Planning
Levick Strategic Communications Advisory Board
Sarasota Memorial Hospital Foundation

Past Boards:
Paracelsus Healthcare - Chairman
Curative Health Services - Chairman Compensation Audit
Dental Benefit Providers - Audit
Lawrence P. English’s career has spanned four decades. He rose to the second highest position at CIGNA Corporation (NYSE CI). When it was clear he would not rise to the CEO role he left the company on mutually satisfactory terms and turned his attention to entrepreneurial pursuits.

During his distinguished 33-year career at CIGNA and its predecessor, Connecticut General Life Insurance Company, Mr. English developed a reputation as a transformation leader. At CIGNA, he served as President of three CIGNA Divisions; CIGNA Reinsurance, CIGNA Individual Insurance and CIGNA HealthCare. He also served as a Trustee of The CIGNA family of Mutual Funds. In his final assignment as President of CIGNA HealthCare, Mr. English had responsibility for 25,000 employees and revenues exceeding $16 billion annually. In his four years as President, CIGNA HealthCare’s annual after-tax profits increased from $250 million to over $400 million.

Since leaving CIGNA, Mr. English has pursued a variety of ventures. From July 1997 to January 1999, Mr. English was Chairman of the Board and Chief Executive Officer of Aesthetics Medical Corporation Management, Inc., a physician practice management company for plastic surgeons. In January 1999 Mr. English founded Lawrence P. English, Inc., a private crisis management and turn-around management firm. In that capacity he served as interim CEO of Amedex Insurance, an International Health Insurance company, and as non executive Chairman of the Board of Paracelsus Healthcare, a for profit hospital chain. In that capacity he oversaw Paracelsus’ filing for and emerging from a Chapter 11 bankruptcy.

Mr. English was recruited to be Chief Executive Officer and a director of QuadraMed (AMEX QD) in June of 2000. From 1993 to 1999 QuadraMed had grown rapidly through acquisition. 27 acquisitions had been completed between 1997 and 1999. By early 2000 it was apparent that the original management had failed to integrate its acquisitions or to realize the promised synergies. As a result the share price collapsed and key managers resigned or were recruited away.

As the new CEO Mr. English recruited a new management team, cut cost, divested non-strategic and underperforming assets and developed a strategy focused on the two product lines that comprise QuadraMed today. Excess cash was used to reduce debt from $110 million at December 31, 1999 to $74 million by December 31, 2001. In response to these aggressive actions the share price rose from a low of $0.65 in December of 2000, to a high of $11.55 in January of 2002.

However, Mr. English’s work at QuadraMed had only begun. During its period of rapid growth the Company’s auditors had been Arthur Andersen. In July of 2002, shortly after the revelation of accounting scandals at Enron, the demise of Arthur Andersen and the enactment of the Sarbanes Oxley law, new auditors forced the Company into a costly and lengthy investigation of past accounting practices, including an extensive forensic review of its acquisition accounting. From July of 2002 through September 2003 Mr. English oversaw a restatement of 13 Quarters of the Company’s financial statement. While the restatement was underway, NASDAQ de-listed the Company’s shares triggering a repayment event for the $74 million in remaining debt. English avoided almost certain bankruptcy by restructuring the debt on favorable terms.

In the early months of 2004 Mr. English settled an SEC investigation of the Company’s accounting and settled shareholder and derivative suits for amounts mostly covered by insurance. He also completed the consolidation of QuadraMed’s headquarters in Reston Virginia. In June of 2004 English raised $100 million of new equity through a Preferred Stock offering. The proceeds were used to extinguish all of QuadraMed’s debt. In August of 2004 the Company’s shares began trading on the American Stock Exchange with the symbol QD. In August of 2005 the Company reported its first operating profits and net income in three years.

Mr. English has been a Director of Curative Healthcare Corporation (NASDAQ CURE) since May 2000. He is chairman of the Compensation Committee and a member of the Audit Committee.

Mr. English is a prominent health care policy thought leader and was a member of the Jackson Hole Group and a founder of the Alliance for Managed Care. He has testified before several Congressional Committees and been featured in numerous publications, including "The Wall Street Journal" and "The New York Times," and has appeared on "The McNeil Lehrer News Hour," "Brokaw on Health," "The Larry King Radio Show," and CNN’s "Business Day."

A native of Philadelphia, born in 1940, Mr. English earned his BA degree from Rutgers University and an MBA from George Washington University. He also is a graduate of the Harvard Business School’s Advanced Management Program. He is a Chartered Life Underwriter and has been a registered principal of the NASD. A U.S. Army veteran, Mr. English served as an active duty Infantry Officer at 18th Airborne Corp and in the 82nd Airborne Division from 1964 to 1966 and as a reserve Special Forces Officer with the 16th Special Forces Group from 1966 to 1969.